Analyst Price Targets — CLMT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:27 pm | Manav Gupta | UBS | $26.00 | $28.51 | TheFly | Calumet price target raised to $26 from $13.25 at UBS |
| January 30, 2026 12:19 pm | Neil Mehta | Goldman Sachs | $24.00 | $22.39 | TheFly | Calumet price target raised to $24 from $20 at Goldman Sachs |
| October 22, 2025 10:23 am | — | Goldman Sachs | $20.00 | $18.67 | TheFly | Calumet price target raised to $20 from $15 at Goldman Sachs |
| August 12, 2025 11:32 am | Manav Gupta | UBS | $13.25 | $13.88 | TheFly | Calumet price target raised to $13.25 from $12 at UBS |
| March 5, 2025 12:25 pm | — | Wells Fargo | $28.00 | $12.98 | TheFly | Calumet price target lowered to $28 from $29 at Wells Fargo |
| December 14, 2022 9:16 am | — | UBS | $15.70 | $13.48 | Benzinga | UBS Initiates Coverage On Calumet Specialty with Neutral Rating, Announces Price Target of $15.7 |
| April 21, 2022 7:25 am | — | Wells Fargo | $29.00 | $14.27 | Benzinga | Wells Fargo Maintains Overweight on Calumet Specialty, Raises Price Target to $29 |
Latest News for CLMT
INDIANAPOLIS, April 6, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that Bradford T. Sanders has been selected as a nominee for election to the Board of Directors of Calumet (the "Board") at the Company's 2026 Annual Meeting of Stockholders (the "Annual Meeting").
Calumet, Inc. (NASDAQ: CLMT - Get Free Report) Director Daniel Sajkowski sold 3,310 shares of the company's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total transaction of $114,062.60. Following the transaction, the director owned 81,958 shares in the company, valued at $2,824,272.68. The
Shares of Calumet, Inc. (NASDAQ: CLMT - Get Free Report) have been given an average rating of "Hold" by the eight brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating on
INDIANAPOLIS, April 2, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet" or the "Company") announced today an operational update for the first quarter of 2026. Shreveport Maintenance Late in the first quarter, our Shreveport facility required unplanned maintenance after discovering the presence of organic chlorides1 in our feedstock tanks.
Calumet, Inc. (CLMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLMT.
U.S. House Trading
No House trades found for CLMT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.